Codes / ICD10CM / F18.14

F18.14 Inhalant abuse with inhalant-induced mood disorder

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Common Name: Inhalant Abuse with Inhalant-Induced Mood Disorder
  • Medical Term: Inhalant Abuse with Inhalant-Induced Mood Disorder

Summary

Inhalant abuse with inhalant-induced mood disorder involves the intentional misuse of inhalants—substances that produce chemical vapors—to achieve psychoactive effects, accompanied by a mood disorder directly resulting from this substance use. This condition combines the behavioral patterns of inhalant misuse with mood-related symptoms, such as depression or mania, that are attributable to the inhalant exposure. It may lead to significant physical and psychological impairment, affecting daily functioning and overall health.

Causes

Inhalant abuse is driven by the repeated misuse of inhalants—commonly household or industrial products like glue, paint thinners, or aerosols—for their psychoactive effects. The mood disorder arises as a direct consequence of this substance use, with the inhalants disrupting neurotransmitter systems and contributing to mood dysregulation. Prolonged or heavy use increases the likelihood of developing mood-related symptoms.

Risk Factors

  • Adolescents and young adults, who are more prone to experimenting with inhalants.
  • Individuals with a history of substance abuse or preexisting mood disorders.
  • Easy access to inhalant products.
  • Lack of supervision or support systems.
  • Co-occurring mental health conditions that may interact with inhalant use.

Symptoms

  • Intense cravings or compulsive inhalant use.
  • Mood disturbances, such as persistent sadness, irritability, or euphoria.
  • Coordination problems, dizziness, or lethargy.
  • Unexplained behavioral changes, including aggression or withdrawal.
  • Cognitive impairment, memory issues, or difficulty concentrating.

Diagnosis

Clinical evaluation includes a detailed history of inhalant use, physical examination, and assessment of mood symptoms. Diagnosis requires confirming that the mood disorder is directly attributable to inhalant use, not another cause. Laboratory tests or imaging may be used to rule out other conditions, and criteria from diagnostic manuals guide the determination of the relationship between inhalant use and mood symptoms.

Treatment Options

Treatment focuses on addressing both the inhalant abuse and the mood disorder. Options may include behavioral therapies, such as cognitive-behavioral therapy, to reduce inhalant use and manage mood symptoms. Medications may be used to stabilize mood, and support groups can aid in maintaining abstinence. Inpatient or outpatient programs may be recommended based on severity.

Prognosis and Follow-Up

Prognosis depends on the duration and severity of inhalant use, as well as the response to treatment. Early intervention improves outcomes, but relapse is possible. Follow-up care involves monitoring for recurrence of inhalant use and mood symptoms, with adjustments to treatment as needed. Long-term management may be required to address both substance use and mood disorders.

Complications

  • Worsening of mood symptoms, including depression or mania.
  • Physical health issues, such as organ damage or neurological impairment.
  • Increased risk of overdose or accidents due to impaired judgment.
  • Social or occupational difficulties from persistent substance use and mood instability.
  • Potential for co-occurring substance use disorders or other mental health conditions.

Lifestyle & Prevention

  • Avoiding exposure to inhalant products and environments where misuse is common.
  • Educating at-risk individuals about the dangers of inhalant use.
  • Building strong support networks to reduce isolation.
  • Engaging in healthy coping mechanisms for stress or emotional challenges.
  • Seeking early help for substance use or mood-related concerns.

When to Seek Professional Help

Seek professional help if inhalant use is frequent or causing mood disturbances, or if symptoms interfere with daily life. Signs include inability to stop using inhalants, worsening mood symptoms, or neglect of responsibilities. Prompt evaluation is important to prevent further harm and initiate appropriate treatment.

Tips for Medical Coders

Document the presence of both inhalant abuse and a mood disorder directly induced by inhalant use. Ensure clinical notes specify the relationship between the mood symptoms and inhalant exposure, as this is critical for accurate coding. Include details on the duration, frequency, and impact of inhalant use, as well as any treatment or follow-up plans, to support code assignment.

Book a walkthrough

F18.14 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.